Li S - Search Results

1

Elucidating the changes in the heterogeneity and function of radiation-induced cardiac macrophages using single-cell RNA sequencing.

Cao C, Wu R, Wang S, Zhuang L, Chen P, Li S, Zhu Q, Li H, Lin Y, Li M, Cao L, Chen J. Cao C, et al. Among authors: li s, li h, li m. Front Immunol. 2024 Mar 27;15:1363278. doi: 10.3389/fimmu.2024.1363278. eCollection 2024. Front Immunol. 2024. PMID: 38601160 Free PMC article.

2

Pretreatment absolute lymphocyte count is an independent predictor for survival outcomes for esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiotherapy and pembrolizumab: An analysis from a prospective cohort.

Qi WX, Wang X, Li C, Li S, Li H, Xu F, Chen J, Zhao S, Li H. Qi WX, et al. Among authors: li c, li s, li h. Thorac Cancer. 2023 Jun;14(17):1556-1566. doi: 10.1111/1759-7714.14898. Epub 2023 Apr 24. Thorac Cancer. 2023. PMID: 37089116 Free PMC article.

3

Nodal response to primary systemic therapy predicts prognosis of cN3c breast cancer patients receiving multimodality therapy.

Li S, Qi W, Cao L, Xu C, Cai R, Chen J, Cai G. Li S, et al. Breast. 2023 Aug;70:92-99. doi: 10.1016/j.breast.2023.06.008. Epub 2023 Jun 27. Breast. 2023. PMID: 37423063 Free PMC article.

4

A machine learning approach using ¹⁸F-FDG PET and enhanced CT scan-based radiomics combined with clinical model to predict pathological complete response in ESCC patients after neoadjuvant chemoradiotherapy and anti-PD-1 inhibitors.

Qi WX, Li S, Xiao J, Li H, Chen J, Zhao S. Qi WX, et al. Among authors: li s, li h. Front Immunol. 2024 Jan 30;15:1351750. doi: 10.3389/fimmu.2024.1351750. eCollection 2024. Front Immunol. 2024. PMID: 38352868 Free PMC article.

5

The addition of pembrolizumab to neoadjuvant chemoradiotherapy did not increase the risk of developing postoperative anastomotic leakage for ESCC: an analysis from a prospective cohort.

Qi WX, Li S, Li H, Chen J, Zhao S. Qi WX, et al. Among authors: li s, li h. BMC Cancer. 2024 Aug 20;24(1):1029. doi: 10.1186/s12885-024-12774-w. BMC Cancer. 2024. PMID: 39164624 Free PMC article.

6

Characterization and dosimetric predictors for absolute lymphocyte count changes during neoadjuvant chemoradiotherapy with or without pembrolizumab for esophageal squamous cell carcinoma: an analysis of a prospective cohort.

Qi WX, Li S, Zhang S, Li C, Li H, Li X, Zhao C, Cai G, Xu C, Han X, Zhang Y, Chen J, Zhao S. Qi WX, et al. Among authors: li s, li c, li h, li x. Radiat Oncol. 2025 Jan 9;20(1):5. doi: 10.1186/s13014-024-02581-9. Radiat Oncol. 2025. PMID: 39789555 Free PMC article.

7

Prognostic value of genomic mutation signature associated with immune microenvironment in southern Chinese patients with esophageal squamous cell carcinoma.

Zhou Y, Chu L, Li S, Chu X, Ni J, Jiang S, Pang Y, Zheng D, Lu Y, Lan F, Cai X, Yang X, Zhu Z. Zhou Y, et al. Among authors: li s. Cancer Immunol Immunother. 2024 Jun 4;73(8):141. doi: 10.1007/s00262-024-03725-2. Cancer Immunol Immunother. 2024. PMID: 38832974 Free PMC article.

8

Overall survival benefit of osimertinib and clinical value of upfront cranial local therapy in untreated EGFR-mutant nonsmall cell lung cancer with brain metastasis.

Zhao Y, Li S, Yang X, Chu L, Wang S, Tong T, Chu X, Yu F, Zeng Y, Guo T, Zhou Y, Zou L, Li Y, Ni J, Zhu Z. Zhao Y, et al. Among authors: li s, li y. Int J Cancer. 2022 Apr 15;150(8):1318-1328. doi: 10.1002/ijc.33904. Epub 2022 Jan 6. Int J Cancer. 2022. PMID: 34914096

9

A narrative review of synergistic drug administration in unresectable locally advanced non-small cell lung cancer: current landscape and future prospects in the era of immunotherapy.

Li S, Chu X, Ye L, Ni J, Zhu Z. Li S, et al. Transl Lung Cancer Res. 2020 Oct;9(5):2082-2096. doi: 10.21037/tlcr-20-512. Transl Lung Cancer Res. 2020. PMID: 33209628 Free PMC article. Review.

10

Pattern of Recurrence Analysis in Metastatic EGFR-Mutant NSCLC Treated with Osimertinib: Implications for Consolidative Stereotactic Body Radiation Therapy.

Guo T, Ni J, Yang X, Li Y, Li Y, Zou L, Wang S, Liu Q, Chu L, Chu X, Li S, Ye L, Zhu Z. Guo T, et al. Among authors: li s, li y. Int J Radiat Oncol Biol Phys. 2020 May 1;107(1):62-71. doi: 10.1016/j.ijrobp.2019.12.042. Epub 2020 Jan 25. Int J Radiat Oncol Biol Phys. 2020. PMID: 31987959

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

100,557 results

Search Page

Filters